Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems
Neuropharmacology, 08/10/09
Stachowicz K et al. – At the same time, ritanserin, the 5–HT2A/C receptor antagonist, did not change the anxiolytic–like effects of ACPT–I. The results of these studies indicate that the GABA–ergic and serotonergic systems are involved in the potential anxiolytic action of ACPT–I.
Related Articles
Additional evidence for the affective dimension of dyspnea in patients with COPD
Research in Nursing & Health, 11/24/09
Relevance Score: 93%
Anxiety and depressive disorders in offspring at high risk for anxiety: A meta-analysis
Journal of Anxiety Disorders, 11/19/09
Relevance Score: 93%
Relationships of Fear, Anxiety, and Depression With Physical Function in Patients With Knee Osteoarthritis
Archives of Physical Medicine and Rehabilitation, 11/06/09
Relevance Score: 92%
Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care
Family Practice, 11/04/09
Relevance Score: 92%
Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients
Multiple Sclerosis, 11/18/09
Relevance Score: 91%
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of Treatment Satisfaction in Children with Allergic Disease Treated with an Antihistamine: An International, Non-Interventional, Retrospective Study
Clinical Drug Investigation, 12/11/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Allos Therapeutics' FOLOTYN Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma
Allos Therapeutics, 12/09/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/14/09
Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial)
Movement Disorders, 12/14/09
Vitamin E Use Is Associated with Improved Survival in an Alzheimer’s Disease Cohort
Dementia and Geriatric Cognitive Disorders, 12/14/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


